NCT06369324Completed
Efficacy of Pain Neuroscience Education and Physiotherapy in Patients Diagnosed with Spondyloarthritis
Source: ClinicalTrials.gov · Last updated 1 Nov 2024
Brief summary (registry, in English)
Spondyloarthritis, notably ankylosing spondylitis (AS), represents a chronic rheumatic condition typified by persistent back pain and stiffness. It constitutes a substantial portion of diagnoses within rheumatology units and exhibits a higher prevalence among males. Diagnosis relies upon comprehensive clinical evaluation, including patient history, physical examination, and adjunctive radiological assessments, with genetic predisposition, particularly the presence of the HLA-B27 antigen, playing a significant role. Management strategies encompass a multidisciplinary approach, with physiotherapy emerging as a cornerstone therapeutic modality. Various exercise interventions, particularly those supervised by trained professionals, demonstrate efficacy in improving pain, stiffness, and overall functional capacity. Furthermore, patient education plays a pivotal role in enhancing treatment adherence and optimizing outcomes by aligning patient expectations with therapeutic goals. The evolving landscape of spondyloarthritis management underscores the necessity of further research into multimodal treatment approaches, particularly in integrating novel interventions such as electrophysical agents. By elucidating the mechanisms of action and exploring their synergistic effects, clinicians can refine treatment protocols and ultimately enhance the quality of care provided to individuals living with spondyloarthritis.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 12 Apr 2024
- Start date
- 15 Feb 2024
- Primary completion date
- 11 Apr 2024
- Lead sponsor
- Universidad de Extremadura
- Diseases
- Ankylosing spondylitis
- NCT number
- NCT06369324
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 15 Feb 2024 to the primary completion date, 11 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Sample subjects with spinal surgery in the last 12 months were excluded.
Other illness
- Subjects with mild/moderate cognitive impairment (score ≥24 in the Spanish validated version for general older adults of the Mini-Mental State Examination) (Lobo A, Saz P, Marcos G et al. Revalidation and standardisation .
Other
- Finally, those with pharmacological treatment that could generate vestibular or balance disturbances at the time of assessment and treatment.
Who the study is looking for
- Adults (men and women) over 18-65 years of age.
- Diagnosed with ankylosing spondylitis by a rheumatologist.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Medicine and Health Sciences Coordinator of this site? Confirm its status | Badajoz | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.